Pejmon Pashai focuses his practice on all aspects of intellectual property litigation, including pre-litigation due diligence, fact discovery, expert discovery, motions practice, and trial preparation. Mr. Pashai has experience litigating cases arising under the Hatch-Waxman Act. His technical experience is in the life sciences and neurophysiology field, where he conducted research in the area of arterial chemoreception at a leading research institution. Mr. Pashai also has experience advising clients on monetizing their software as a service (SaaS) and preparing end-user license agreements (EULAs).

Prior to joining Dechert, Mr. Pashai was an attorney in the Washington, D.C. office of an international law firm.

    • Major brand pharmaceutical companies in litigation arising under the Hatch-Waxman Act against eight generic drug manufacturers. 
    • Multiple brand pharmaceutical companies on pre-litigation due diligence and Orange Book listing.  

    Includes matters handled prior to joining the firm.